National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 1468026

History of Changes from the VAERS Wayback Machine

First Appeared on 7/16/2021

VAERS ID: 1468026
VAERS Form:2
Age:32.0
Sex:Female
Location:Foreign
Vaccinated:2021-06-04
Onset:2021-06-04
Submitted:0000-00-00
Entered:2021-07-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH FA8016 / 1 LA / OT

Administered by: Other      Purchased by: ??
Symptoms: Asthenia, Culture throat, Threatened labour, Ultrasound scan, Urine analysis, Investigation, Vaccination site pain, Maternal exposure during pregnancy, SARS-CoV-2 test

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? Yes
Hospitalized? Yes, days: 3     Extended hospital stay? No
Previous Vaccinations:
Other Medications: TIMOFEROL
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Penicillin allergy; Rhinitis allergic; Surgery (adenoid surgery)
Allergies:
Diagnostic Lab Data: Test Date: 20210605; Test Name: throat swab; Test Result: Negative ; Test Date: 20210605; Test Name: infective workup with pyretism; Test Result: Negative ; Comments: Negative infective workup with pyretism; Test Date: 20210605; Test Name: vaginal swab; Test Result: Negative ; Comments: negative vaginal swab; Test Date: 20210605; Test Name: SARS-CoV-2 test; Test Result: Negative ; Test Date: 20210605; Test Name: ultrasound of the cervix; Result Unstructured Data: Test Result:cervix at 26 mm; Comments: cervix at 26 mm with minimal image of the water pocket, The uterus is contractile with painful contractions.; Test Date: 20210608; Test Name: Ultrasound of the exit cervix; Result Unstructured Data: Test Result:cervix at 29-30 mm.; Comments: Ultrasound of the exit cervix: cervix at 29-30 mm.; Test Date: 20210605; Test Name: cytobacteriological examination of urine; Result Unstructured Data: Test Result:sterile; Comments: sterile cytobacteriological examination of urine
CDC 'Split Type': FRPFIZER INC2021796162

Write-up: Threatened premature labor; Maternal exposure during pregnancy; Asthenia; Vaccination site pain; This is a spontaneous report from a contactable consumer from the WEB, regulatory authority number FR-AFSSAPS-2021072533. A 32-years-old pregnant female patient received bnt162b2 (COMIRNATY), dose 1 intramuscular, administered in the left arm on 04Jun2021 (Batch/Lot Number: FA8016) as dose 1, single (at the age of 32 years-old) for COVID-19 immunisation. Medical history included allergic rhinitis, adenoids surgery, unexplored penicillin hypersensitivity. The patient had no previous obstetric history. Concomitant medications included ascorbic acid, ferrous sulfate (TIMOFEROL) from an unknown date for an unspecified indication. On 04Jun2021 the patient experienced threatened premature labor, asthenia, and vaccination site pain. The mother was 29 Weeks + 6 days pregnant at the onset of the event (04Jun2021). No data if spontaneous pregnancy, G1P0. Date of LMP was 08Nov2020, either estimate DDR 08Nov2020 or early pregnancy 21Nov2020. The mother was due to deliver on 15Aug2021. The patient was hospitalized from 05Jun2021 to 08Jun2021 for threat of premature delivery. Clinical course is as follows: on 04Jun2021, 5 hours after vaccination onset of pain at the injection site, onset also on the same day of asthenia, 15 hours after vaccination onset of contraction episodes (at night) leading to an emergency room visit. On 05Jun2021 the patient underwent lab tests and procedures which included: an ultrasound of the cervix was performed with results: cervix at 26 mm with minimal image of the water pocket. The uterus was contractile with painful contractions. Negative infective workup with pyretism, sterile cytobacteriological examination of urine, negative vaginal swab, negative throat swab and negative COVID PCR. On 08Jun2021 Relay by SPASFON, Ultrasound of the exit cervix: cervix at 29-30 mm. The patient no longer presented with painful uterine contractions. Monitoring was reassuring. The differential diagnosis was provided as: infectious causes: negative assessment, afebrile; maternal causes: G1P0, age less than 35 years, minimal water bag rate but no data on socio-economic level, tobacco / toxic, NF (anemia?), type of work, trauma, T2 / T3 metrorrhagia, long daily trips; Obstetric history: 0; ovular causes: not mentioned but a priori no hydramnios or placenta preavia. The patient was healing and discharge from the hospital on 08Jun2021 with prescription for AT from 05Jun2021 to 11Jun2021, SPASFON 80mg 2-2-2 PARACETAMOL 1g 1-1-1, with recommendations of Midwife follow-up at home twice a week until childbirth and for patient to change position every 2 hours, avoid long journeys by car, avoid intense physical activity, and keep walking at a moderate pace. Therapeutic measures were taken as a result of threatened premature labor and included establishment of an ADALATE LP 20mg protocol for 48h and the patient also benefited from corticosteroid therapy with CELESTENE in IM 2 times at 24 hour intervals for fetal lung maturation. The clinical outcome of the event threatened premature labor was recovered on 08Jun2021, asthenia recovered on an unknown date and vaccination site pain recovered on 05Jun2021. No follow-up attempts possible. No further information expected.

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?IDNUMBER=1468026&WAYBACKHISTORY=ON


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166